News

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine

Schlieren (Zurich), 20 July 2023 - LimmaTech Biologics AG (“LimmaTech Bio”), a clinicalstage biotech company developing vaccines for the prevention of life-threatening diseases, signed an in-license agreement with GlaxoSmithKline Biologicals SA (LSE/NYSE: GSK) enabling LimmaTech Bio to further develop and commercialize a quadrivalent bioconjugate vaccine candidate for shigellosis that GSK...

read more

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

Schlieren (Zurich), Switzerland, July 13, 2023 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today the completion of enrollment in the STRUCTURE trial, which is investigating the safety and efficacy of Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion (TLIF) procedures in...

read more

Schlieren BBQ sponsored by LubioScience

  When? Thursday, July 06, 2023, 11:30 - 14:00 Where? Between the Roche Tower and Wagi S Fancy a sausage hot off the grill? Or a spicy veggie option? Then join us for our BBQ event in Schlieren and meet the Lubio team! Ready for the party? Register here no later than June 30. Registration is mandatory...

read more

Booth from Euresearch in the cafeteria WAGI-S from 11am-14pm

Are you aware that many Horizon Europe Calls are currently open for proposal submissions with funding opportunities in your research field? Swiss entities CAN participate in most Horizon Europe calls. Funding is provided by the Swiss government – also to companies – as long as Switzerland is not associated to the program. Wishing to...

read more